D. S. Davenport

Usefulness of a Test for Slime Production as a Marker for Clinically Significant Infections with Coagulase-Negative Staphylococci

D. S. Davenport, R. Michael Massanari, Michael A. Pfaller et al. · The Journal of Infectious Diseases · 1986 · 228 citations

Hospital Records, Clinically Significant Infections, Slime Production +14

Recommendations for Prevention of and Therapy for Exposure to B Virus (<i>Cercopithecine Herpesvirus</i>1)

Jeffrey I. Cohen, D. S. Davenport, John A. Stewart et al. · Clinical Infectious Diseases · 2002 · 184 citations

Vaccination, Diagnostic Virology, B Virus Infection +15

Guidelines for the Prevention and Treatment of B-Virus Infections in Exposed Persons

Gary P. Holmes, Louisa E. Chapman, John A. Stewart et al. · Clinical Infectious Diseases · 1995 · 132 citations

Viral Pathogenesis, Hepatitis B, Simian Retrovirus Infection +16

Diagnosis and Management of Human B Virus (Herpesvims simiae) Infections in Michigan

D. S. Davenport, Deborah R. Johnson, Gary P. Holmes et al. · Clinical Infectious Diseases · 1994 · 67 citations

Herpesvirus Simiae, Virus Epidemiology, Viral Diagnostics +25

Development of the quantitative micro-test for slime production by coagulase-negative staphylococci

Michael A. Pfaller, D. S. Davenport, Martha J. Bale et al. · European Journal of Clinical Microbiology & Infectious Diseases · 1988 · 54 citations

Slime Production, Quantitative Micro-test, Coagulase-negative Staphylococci +5